Quantcast
Last updated on April 18, 2014 at 12:23 EDT

Latest Micropharma Limited. Stories

2013-12-10 08:29:54

Microbiome Plus+ Bone, Heart and GI are the first disease specific microbiome-based supplements to market MONTREAL, Dec. 10, 2013 /PRNewswire-iReach/ -- Micropharma Limited, a pioneer in the development of microbiome based technologies announced today the launch of an innovative new line of dietary supplements called Microbiome Plus+. Microbiome Plus+ products are the first line of dietary supplements based on the exciting new science of the microbiome. Microbiome Plus+ products...

2013-04-26 12:27:38

MONTREAL, April 26, 2013 /PRNewswire-iReach/ -- Micropharma Limited, a pioneer in the development of innovative and effective products based on the human microbiome, today announced that after three years of development it has a timeline for launch of its ingestible gastrointestinal sampling technology. The company released its plans to launch the device in late 2014 commercially for research and development use and later for specific clinical applications. Micropharma has been...

2013-02-27 16:26:51

MONTREAL, Feb. 27, 2013 /PRNewswire/ -- Micropharma Limited, a pioneer in the development of innovative and effective probiotics, today announced that their heart health probiotic, Cardioviva(TM) (Lactobacillus reuteri NCIMB 30242), has obtained "Generally Recognized as Safe" (GRAS) status. This U.S. Food and Drug Administration (FDA) designation signifies that Cardioviva(TM) is considered safe by experts to use as an ingredient in food. Of the top 10 probiotic supplements in the U.S.,...

2012-11-05 12:26:24

LOS ANGELES, Nov. 5, 2012 /PRNewswire/ -- Micropharma Limited today announced plans to launch Cardioviva(TM) (Lactobacillus reuteri NCIMB 30242), the world's only probiotic shown to naturally help reduce LDL-cholesterol, a risk factor for heart disease, by 11.6 percent in hypercholesterolemic adults. Micropharma will launch Cardioviva(TM) in Canada and in the U.S. in early 2013. The announcement was made after an American Heart Association (AHA) Scientific Sessions press conference today...

2012-09-19 06:27:52

MONTREAL, Sept. 19, 2012 /PRNewswire/ -- Micropharma Limited, a pioneer in the development of innovative and effective probiotics, has filed a number of patents for its probiotic technologies. Probiotics - bacteria that confer a health benefit to the host - are being studied to determine if they may have a more significant role in helping to maintain and improve health and wellness through the gut. And emerging science is evaluating whether supplementing the microbiome (gut bacteria) with...

2012-09-05 06:28:55

MONTREAL, Sept. 5, 2012 /PRNewswire/ -- In advance of September's National Cholesterol Education Month, a roundtable of leading global experts in heart health, probiotics and nutrition convened in Chicago to discuss the development of a new scientific review paper looking at a new role for probiotics in cardiovascular disease. The August 23 roundtable participants included: Richard J. Deckelbaum, MD, CM, FRCPC, Robert R. Williams Professor of Nutrition, Professor of Pediatrics, Professor...

2012-07-05 02:24:07

MONTREAL, July 5, 2012 /PRNewswire/ -- Micropharma Limited, a pioneer in the development of innovative and effective probiotics, announced today its plans to launch a portfolio of natural supplements and food ingredient solutions aimed at addressing specific health markers to help maintain and improve health and wellness. Adding to its strong pipeline with eight patents filed since 2003, the first probiotic to be launched later this year has been clinically shown to maintain healthy...